Microdosing aims to extend the lifespan of the GLP-1 compounding market

The race is on to turn your body into a GLP-1 factory

People looking to lose weight and lower their blood sugar may someday be able to get a single injection that turns their cells into tiny factories that churn out a protein that is essentially the active ingredient in drugs like Ozempic, Wegovy, Zepbound and Mounjaro.

Microdosing aims to extend the lifespan of the GLP-1 compounding market

Noom, Found, and Hims & Hers have all launched programs to prescribe “microdosed” GLP-1s in the last three months, following in the footsteps of many smaller direct-to-consumer telehealth companies. Microdosing is getting a shot of promotion from Hollywood, too: Noom has promoted its program alongside a new celebrity spokesperson, actor Rebel Wilson, and TV host Andy Cohen has been doing the rounds talking about his microdosing habit.  In their …